Aspirin-induced long-term tumor remission in hepatocellular carcinoma with adenomatous polyposis coli stop-gain mutation: A case report

Figure 1 Patient information. A: Changes in alpha fetoprotein during treatment. B: Mutation map of adenomatous polyposis coli domains; C: Changes in tumor masses by magnetic resonance imaging before and after aspirin treatment. APC: Adenomatous polyposis coli; TACE: Transcatheter arterial chemoembolization.

Figure 2 Gene mutation profiles. A: Patients with hepatitis B-related hepatocellular carcinoma (HCC, n = 41); B: Global HCC population from the Catalogue of Somatic Mutations in Cancer database. COSMIC: Catalogue of Somatic Mutations in Cancer database.